Search Results - Gary Mo

A phase 1, multicenter, open‐label study to evaluate the pharmacokinetics, safety, and tolerability of a single dose of rimegepant in children (aged ≥6 to <12 years) with a history... Autoría: Chay Ngee Lim, Gary Mo, Rajinder Bhardwaj, Craig M. Comisar, Beth L. Emerson, Kyle T. Matschke, Ogert Fisniku, Richard Bertz, Robert Croop, Jing Liu